Organization · Incubator
Alderley Park
Alderley Park is a 400-acre innovation campus in Cheshire, UK, specializing in office and laboratory spaces for life sciences and technology companies. It supports over 250 businesses with facilities and programs aimed at fostering collaboration and innovation.
Overview
What Alderley Park does
What Alderley Park is
Alderley Park is a 400-acre innovation campus in Cheshire, UK, specializing in office and laboratory spaces for life sciences and technology companies. It supports over 250 businesses with facilities and programs aimed at fostering collaboration and innovation.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Incubator
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- May 2, 2026
What Incubator means
An incubator is a support environment for turning a nascent idea or early company into a startup that is more ready for customers, funding, or an accelerator.
Open the glossary entryOfficial channels
Find Alderley Park elsewhere
Open the official website or a supported primary organization account.
Capability profile
Alderley Park as a funder
Investment thesis
Alderley Park's thesis is ecosystem-led life-science company building: give early-stage science companies the specialist lab infrastructure, business-model support, sector partners, and investor readiness needed to move from lab concept toward commercialisation.
Focus narrative
Alderley Park provides office and laboratory spaces tailored for businesses in the biotechnology, pharmaceuticals, diagnostics, and technology sectors. The campus supports companies at various stages of development, from startups to established enterprises, and emphasizes collaboration and innovation. It also offers access to investment opportunities and strategic partnerships through its ecosystem.
Value beyond capital
Alderley Park offers access to advanced drug discovery technologies, specialist expert support, industry events, and investor-readiness advice from partners including Deepbridge Capital and DSW Ventures. The campus provides free lab space for accelerator participants and facilitates connections with potential investors.
Terms and economics
- Typical check
- $50,000–$2,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Accelerator
- Sectors
- Biotech · Healthcare · Digital Health · Drug Discovery · Diagnostics
- Regions
- United Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 250
Portfolio context
Alderley Park hosts a diverse range of companies, particularly in the life sciences and technology sectors. Notable initiatives include: Medicines Discovery Catapult (MDC): A national facility that provides drug discovery expertise and technology to accelerate the development of new medicines. GMC Life Sciences Fund by Praetura: A £20 million venture capital fund aimed at supporting early-stage businesses in Greater Manchester, Cheshire, and Warrington. Revvity: Global life-sciences and diagnostics company that joined Alderley Park in 2025 as a UK hub for work tied to a Genomics England collaboration. F2G: Antifungal-therapy developer that chose Alderley Park as its new UK headquarters after a $100M fundraising round in late 2024.
Capability profile
Alderley Park as a program host
Program thesis
Alderley Park's thesis is ecosystem-led life-science company building: give early-stage science companies the specialist lab infrastructure, business-model support, sector partners, and investor readiness needed to move from lab concept toward commercialisation.
Focus narrative
Alderley Park provides office and laboratory spaces tailored for businesses in the biotechnology, pharmaceuticals, diagnostics, and technology sectors. The campus supports companies at various stages of development, from startups to established enterprises, and emphasizes collaboration and innovation. It also offers access to investment opportunities and strategic partnerships through its ecosystem.
Value and support
Alderley Park offers free lab space, specialist expert support, industry events, investor-readiness advice, and potential SEIS funding during or immediately after the program.
Additional public guidance
Q: What types of companies does Alderley Park support? A: Alderley Park supports early-stage life-science companies and established enterprises in biotechnology, pharmaceuticals, diagnostics, and technology sectors. Q: How can I apply to the Life Science Accelerator? A: Applications are accepted through the Bruntwood SciTech website.
Terms and economics
- Indicative investment
- $2,000,000
Format and cadence
- Typical duration
- 26 weeks
- Format
- Hybrid
Availability
- Application state
- Accepting
Focus and fit
- Stages
- Accelerator · Seed
- Regions
- Uk · Greater China
Alumni and track record
Alumni context
Notable alumni include Revvity, a global life-sciences and diagnostics company; F2G, an antifungal-therapy developer; and Medicines Discovery Catapult, a national facility that provides drug discovery expertise.
Common questions
What to know about Alderley Park
Upseed classifies Alderley Park under the Incubator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 2, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.